Skip to main content

Prevacent PRRS

This page contains information on Prevacent PRRS for veterinary use.
The information provided typically includes the following:
  • Prevacent PRRS Indications
  • Warnings and cautions for Prevacent PRRS
  • Direction and dosage information for Prevacent PRRS

Prevacent PRRS

This treatment applies to the following species:
Company: Elanco US

Porcine Reproductive & Respiratory Syndrome Vaccine, Reproductive & Respiratory Form, Modified Live Virus

For Use In Animals Only





Prevacent PRRS Indications

This product has been shown to be effective for the vaccination of healthy pigs 2 weeks of age or older against PRRS respiratory disease; and against reproductive disease when vaccinated 6 weeks prior to breeding. The duration of immunity against respiratory disease is at least 26 weeks. The duration of immunity against reproductive disease has not been established. For more information regarding efficacy and safety data, go to

Safety of this product has been demonstrated when sows or gilts are vaccinated prior to breeding or at any stage of pregnancy. Vaccine virus may be shed and transmitted to other populations of swine in contact with vaccinated swine. The duration of potential vaccine virus transmission may vary. Use of the vaccine in herds intended to remain PRRS virus seronegative is contraindicated. Introduction of vaccinated pigs into herds intended to remain PRRS virus seronegative is contraindicated.

Dosage and Administration

Rehydrate with the accompanying sterile diluent. Shake well and draw back into the syringe the required amount. Administer 1 mL intramuscularly. The need for annual booster vaccinations has not been established for this product; consultation with a veterinarian is recommended.


Store at 2°-8°C (35°-46°F). Do not freeze. Use entire contents when first opened. Do not mix with other products, except as specified on the label. In case of human exposure, contact a physician. Do not vaccinate within 21 days before slaughter. Inactivate unused contents before disposal. Anaphylactic reactions may occur. Symptomatic treatment: Epinephrine. Contains gentamicin as preservative.

Prevacent, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates.

VLN/PCN: 196/19S1.20

Elanco US Inc., Fort Dodge, IA 50501


20 Doses

20 mL

SH102736C, YL102736A

100 Doses

100 mL

SH102736A, YL102736E

250 Doses

250 mL

SH102736B, YL102736C

CPN: 1943040.3

Distributed by ELANCO US, INC.
Customer Service:   317-276-1262
Technical Service:   800-428-4441
THIS SERVICE AND DATA ARE PROVIDED "AS IS". DVMetrics assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the DVMetrics service and data. See the Terms of Use for further details.

Copyright © 2023 Animalytix LLC. Updated: 2023-05-30